Who invested in Artax Biopharma?
Artax Biopharma's investors include U.S. Venture Partners, Eli Lilly, Advent Life Sciences Llp and Henri Termeer.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$21Mraised across 4 rounds since 2013, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $6.0M sold, first sale Jul 2024
From a historical funding recordSEC filing: $3.0M sold, first sale Jul 2015
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Jul 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.3M sold, first sale Jun 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Artax Biopharma's investors include U.S. Venture Partners, Eli Lilly, Advent Life Sciences Llp and Henri Termeer.
Artax Biopharma has raised $21M across 4 rounds since 2013.
Artax Biopharma's most recent round was an Undisclosed round of $8.0M in Aug 2024.
Artax Biopharma's largest round on record is $10M (Series B), in Sept 2015.
Artax Biopharma's first round on record, in Sept 2015, was backed by Advent Life Sciences Llp and Henri Termeer.
Artax Biopharma's latest named round is an Undisclosed round, in Aug 2024.
Artax Biopharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.